CVS' move to lean on ICER data could mean dramatic shift in drug pricing leverage

13th August 2018 Uncategorised 0

As part of a war between payers and drugmakers, CVS Caremark will allow clients to incorporate ICER analyses into their coverage decisions.

More: CVS' move to lean on ICER data could mean dramatic shift in drug pricing leverage
Source: fierce